Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Debt Ratio (2020 - 2023)

Mirum Pharmaceuticals (MIRM) has 4 years of Debt Ratio data on record, last reported at 0.0 in Q1 2023.

  • For Q1 2023, Debt Ratio fell 54.46% year-over-year to 0.0; the TTM value through Mar 2023 reached 0.0, down 54.46%, while the annual FY2022 figure was 0.0, 54.41% down from the prior year.
  • Debt Ratio reached 0.0 in Q1 2023 per MIRM's latest filing, up from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.01 in Q2 2021 and bottomed at 0.0 in Q4 2022.
  • Average Debt Ratio over 4 years is 0.01, with a median of 0.01 recorded in 2020.
  • Peak YoY movement for Debt Ratio: soared 71.48% in 2022, then tumbled 54.46% in 2023.
  • A 4-year view of Debt Ratio shows it stood at 0.01 in 2020, then increased by 29.09% to 0.01 in 2021, then plummeted by 54.41% to 0.0 in 2022, then grew by 5.81% to 0.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.0 in Q1 2023, 0.0 in Q4 2022, and 0.0 in Q3 2022.